Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model
- 13 January 2008
- journal article
- research article
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 20 (6), 680-688
- https://doi.org/10.1111/j.1365-2982.2007.01065.x
Abstract
Efforts to define either a biomarker for irritable bowel syndrome (IBS) or a valid animal model have proven disappointing. The aims of this study were to determine if buspirone stimulates prolactin release through the 5‐hydroxytryptamine (5HT)1a receptor and whether this response is altered in patients with IBS and in the rat maternal separation model. Buspirone (30 mg) was used to stimulate prolactin release in 40 patients with IBS and in 40 healthy controls. In study 1, 10 IBS patients and 10 controls underwent pretreatment with pindolol (5HT1a antagonist) or placebo followed by buspirone. In study 2, 30 patients with IBS and 30 healthy controls had prolactin release stimulated by buspirone. Maternally separated and nonseparated rats were also treated with buspirone and prolactin monitored. Serotonin metabolites were measured together with the expression of the 5HT1a and serotonin transporter (SERT) gene. Pindolol produced a dose‐dependent decrease in the buspirone prolactin response. Patients with IBS and maternally separated rats showed an exaggerated release of prolactin in response to buspirone. In the animal model, an increased turnover of 5HT was found in the brainstem together with a trend toward increased activity of the SERT gene. In conclusion altered central serotonin responses are found in both IBS and in an animal model.Keywords
This publication has 39 references indexed in Scilit:
- The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI DisordersGastroenterology, 2007
- Drugs Acting on Serotonin Receptors for the Treatment of Functional GI DisordersDigestive Diseases, 2006
- Blockade of 5-HT1A Receptors by (±)-Pindolol Potentiates Cortical 5-HT Outflow, but not Antidepressant-Like Activity of Paroxetine: Microdialysis and Behavioral Approaches in 5-HT1A Receptor Knockout MiceNeuropsychopharmacology, 2006
- Efficacy of the 5‐HT1A Agonist, Buspirone Hydrochloride, in Migraineurs With Anxiety: A Randomized, Prospective, Parallel Group, Double‐Blind, Placebo‐Controlled StudyHeadache: The Journal of Head and Face Pain, 2005
- Acute Tryptophan Depletion. Part I: Rationale and MethodologyAustralian & New Zealand Journal of Psychiatry, 2005
- Genetics and Genotypes in Irritable Bowel Syndrome: Implications for Diagnosis and TreatmentGastroenterology Clinics of North America, 2005
- Is there a SERT-ain association with IBS?Gut, 2004
- Central serotonin receptors and delayed gastric emptying in non-ulcer dyspepsia.BMJ, 1992
- Serotonin Supersensitivity: The Pathophysiologic Basis of Non-Ulcer Dyspepsia?: A Preliminary Report of Buspirone/Prolactin Responses: Preliminary ReportScandinavian Journal of Gastroenterology, 1990
- Plasma prolactin changes following fenfluramine in depressed patients compared to controls: An evaluation of central serotonergic responsibility in depressionLife Sciences, 1984